Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target

Inflammatory breast cancer (IBC) is a rare but aggressive subtype of breast cancer, mainly characterized using primary tumor samples. Here, using public datasets, we compared the genomic alterations in primary and metastatic samples from patients with metastatic IBC versus patients with metastatic n...

Description complète

Détails bibliographiques

Auteurs principaux:	François Richard, Maxim De Schepper, Marion Maetens, Sophia Leduc, Edoardo Isnaldi, Tatjana Geukens, Karen Van Baelen, Ha-Linh Nguyen, Peter Vermeulen, Steven Van Laere, François Bertucci, Naoto Ueno, Luc Dirix, Giuseppe Floris, Elia Biganzoli, Christine Desmedt
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2023-06-01
Collection:	Breast
Sujets:	Inflammatory breast cancer Metastatic breast cancer Genomic alterations AURKA-Inhibitors
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S0960977623000103
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!